Nicorette Invisi (Nicotine)

Nicotine, the active ingredient in Nicorette Invisi, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adults who want to quit smoking by reducing withdrawal symptoms and cravings associated with nicotine dependence.

GNH USA supplies Nicorette Invisi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicotine, delivered via Nicorette Invisi, is used in nicotine replacement therapy to support smoking cessation.

- Smoking cessation: reduces cravings and withdrawal symptoms in adults attempting to quit smoking. - Tobacco dependence: provides a controlled nicotine dose to facilitate gradual reduction of nicotine intake. - Relapse prevention: helps maintain abstinence by mitigating occasional urges to smoke.

Common Side Effects: - Skin irritation at the application site: redness, itching, or mild rash. - Localized burning or tingling sensation where the patch is applied. - Headache: mild to moderate intensity. - Nausea or upset stomach. - Sleep disturbance: vivid dreams or difficulty falling asleep.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives, or severe rash. - Severe skin reaction: blistering or dermatitis. - Dizziness or fainting episodes. - Chest pain or palpitations. - Unexplained hypertension. - Seizures (very rare).

Before using Nicorette Invisi, consider the following precautions: - Assess cardiovascular status: nicotine may increase heart rate and blood pressure. - Avoid use in uncontrolled hypertension: monitor blood pressure regularly. - Do not use if known allergy to nicotine or patch components. - Apply to intact, non‑irritated skin only; avoid broken or damaged areas. - Pregnancy and breastfeeding: consult a healthcare professional; safety not established. - Store at room temperature: keep in the original pouch, protect from moisture and direct sunlight.

Nicotine patches can interact with several medicines. Review the following categories:

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase hypertensive risk. - Bupropion or other seizure‑threshold‑lowering agents: combined use may raise seizure risk. - Concurrent nicotine products (e.g., gum, lozenges): risk of nicotine overdose.

Moderate Interactions (Monitor Closely): - Caffeine‑containing beverages or drugs: nicotine may enhance stimulant effects. - Beta‑blockers: nicotine may reduce their efficacy in controlling heart rate. - Antihypertensive agents: nicotine may counteract blood‑pressure‑lowering effects.